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Abstract
Background—Cancer disparities within and across populations provide insight into the 
influence of lifestyle, environment, and genetic factors on cancer risk.
Methods—Guam cancer incidence and mortality were compared to that of Hawaii using data 
from their respective population-based, central cancer registries.
Results—In 2009-2013, overall cancer incidence was substantially lower in Guam than in 
Hawaii for both sexes while overall cancer mortality was higher for Guam males. Cervical cancer 
incidence and prostate cancer mortality were higher in Guam. Both incidence and mortality were 
higher among Guam men for cancers of the lung & bronchus, liver & intrahepatic bile duct, and 
nasopharynx; Chamorro men were disproportionately affected by these cancers. Filipinos and 
Whites in Guam had lower overall cancer incidence compared to Filipinos and Whites in Hawaii. 
Although breast cancer incidence was significantly lower in Guam compared to Hawaii, women in 
Guam presented at younger ages and with rarer disease histologies such as inflammatory 
carcinoma were more prevalent. Guam patients were also diagnosed at younger ages for cancers of 
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bladder, pancreas, colon & rectum, liver & intrahepatic bile duct, lung & bronchus, stomach, non-
Hodgkin lymphoma, and leukemia.
Conclusion—Smoking, infectious agents, and betel nut chewing appear to be important 
contributors to the burden of cancer in Guam. Earlier onset of cancer in Guam suggests earlier age 
of exposure to key risk factors and/or a more aggressive pathogenesis. Contrasting cancer patterns 
within Guam and between Guam and Hawaii underscore the potential influence of genes, lifestyle, 
and environmental factors on cancer development and progression.
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Introduction
The burden of cancer varies globally by geographic regions, locations and across racial and 
ethnic populations. Guam and Hawaii are each comprised of unique ethnically diverse 
populations including indigenous peoples and individuals of Asian, European, and Pacific 
Island ancestry. Guam, a U.S. territory located in the Western Pacific, is the largest island in 
Micronesia with a population of approximately 159,000.[1] Guam's population includes 
indigenous Chamorros (including part-Chamorros) (42.2%), Filipinos (26.3%), Chuukese 
and other Micronesians (7.2%), Whites (6.8%), other Asians (6.2%), and other race/ethnic 
groups (11.3%). [1, 2] Hawaii, the 50th U.S. state located in the Central Pacific, consists of a 
population of 1,360,000 residing on six main islands. [3] Hawaii's population is comprised 
of indigenous Native Hawaiians (including part-Hawaiians) (21.3%), Whites (22.8%), 
Filipinos (17.2%), Japanese (16.3%), Chinese (6.8%), and other race/ethnicities (15.6%). [3]
The contribution of Hawaii's multiethnic population to its cancer burden has long been 
recognized based on numerous epidemiologic studies conducted over more than four 
decades. [4-11] These studies have provided important insight into cancer development and 
progression across Hawaii's population and the interacting influence of genes with lifestyle, 
diet, environment, and other factors. In contrast, infrastructure and resources for cancer 
surveillance and cancer research were not established in Guam until relatively recently. 
Consequently, there is limited knowledge of the epidemiology of the cancer in this island 
population. Ethnic variation in cancer incidence and mortality across Guam's population has 
been observed.[12, 13] Prevalent exposures such as cigarette smoking and Areca (betel) nut 
chewing likely influence disease risk [14, 15].
The present report utilizes cancer surveillance data to characterize and compare the current 
burden of cancer in Guam and Hawaii. Ethnic comparisons focus on variation within Guam's 
major ethnic groups. Elucidation of factors influencing cancer risk and progression is key to 
informing future research and public health efforts for Guam's population.
Materials and Methods
The present analysis utilized cancer registry data from cases diagnosed in 2009-2013 in 
Guam and Hawaii. The Guam Cancer Registry (GCR) was established as a unit of the 
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University of Guam (UOG) in 2004 through a partnership of the UOG, the Guam 
Department of Public Health and Social Services, and the University of Hawaii Cancer 
Center. The GCR is partly supported through the University of Hawaii-University of Guam 
Partnership (NCI 5 U54 CA143727). The Guam Cancer Registry is also a member and 
reporting registry of the Pacific Regional Central Cancer Registry (PRCCR) (CDC U58 
DP000976 and U58 DP003906). PRCCR consists of cancer registries covering the U.S. 
Affiliated Pacific Islands including Guam, American Samoa, the Commonwealth of the 
Northern Mariana Islands, the Federated States of Micronesia, the Republic of the Marshall 
Islands, and the Republic of Belau (Palau). The GCR offices at the UOG serve as the central 
host location for PRCCR. The GCR is responsible for the collection of data on newly 
diagnosed cancer cases and annual follow-up of existing cases throughout the territory of 
Guam. Data is collected, coded, and maintained based on standards of the CDC National 
Program of Cancer Registries and the North American Association of Central Cancer 
Registries (NAACCR).
The Hawaii Tumor Registry (HTR) of the University of Hawaii Cancer Center (UHCC) was 
established in 1960 and has been a part of the National Cancer Institute's Surveillance 
Epidemiology and End Results (NCI/SEER) Program since 1973. The HTR is responsible 
for cancer surveillance for the state of Hawaii and contributes to U.S. cancer incidence, 
mortality, and survival data.[16] The HTR works closely with the GCR to provide technical 
assistance and training.
Comparisons of cancer in Guam and Hawaii necessitate consideration of certain limitations 
in the quality of data from the GCR as a relatively new central cancer registry. For 
2009-2013, GCR data met the standards of data completeness [17] for the proportion of 
cases with unknown age, sex, and residence (0% for all). However, the proportions of 
unknown race/ethnicity and death certificate-only cases were 7.1% and 11%, respectively, 
which did not meet data quality standards.
Site, and histology were coded according to the International Classification of Diseases for 
Oncology (ICD-O), Third Edition. [18] Cancer sites and stage at diagnosis were categorized 
according to WHO and SEER definitions [19] The present analysis was limited to invasive 
cancers with the exception of bladder cancer, which includes both in situ and invasive 
cancers consistent with SEER standards. Demographic, clinical, and pathologic information 
was available from both registries. The GCR data also included cancer-screening history for 
a subset of cases.
Average annual age-adjusted incidence and mortality rates per 100,000 were calculated for 
the 5–year period, 2009-2013. Rates were age-standardized to the World Health 
Organization 2000-2025) World Standard Million Population. Ninety-five percent 
confidence intervals were calculated for all rates. To ensure the stability and reliability of 
rates, incidence and mortality rates were limited to sex-ethnic categories with at least 10 
cases or deaths over the 5-year period. Overall incidence comparisons in Guam included 
Chamorros, Filipinos, and Whites (Caucasians). Hawaii comparisons included Whites 
(Caucasians), Japanese, Native Hawaiian, Filipino, and Chinese. Unpaired t-tests, Wilcoxon 
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two-sample tests, and Pearson's chi square statistics were used to compare continuous and 
categorical variables; p-values less than 0.05 were considered significant.
Results
Cancer Incidence
In 2009-2013, cancer was diagnosed in 1,708 individuals (342 per year) in Guam and 33,521 
individuals (6,704 per year) in Hawaii, respectively. The overall cancer incidence was 
significantly lower in Guam than in Hawaii for both sexes (Males: 248.9, 95% CI 232.5 - 
266.2 and 329.3, 95% CI 324.2 - 334.5 per 100,000, respectively; Females: 211.2, 95% CI 
196.9 -226.3 and 317.3, 95% CI 312.1 - 322.4 per 100,000, respectively). (Hereafter all 
incidence and mortality rates shown exclude “per 100,000”).
Overall cancer incidence varied across the major race/ethnic groups of both island 
populations. In Guam, among both sexes, overall incidence was significantly higher in 
Whites and Chamorros compared to Filipinos (Figure 1). In Hawaii, overall incidence 
among males was highest for Whites, followed by Native Hawaiians, then Filipinos and 
Japanese--whose rates were comparable--, and Chinese, who had the lowest incidence 
(Figure 2). Overall incidence among Hawaii females was highest for Native Hawaiians and 
Whites, followed by Japanese, and Filipinos, and lowest in Chinese (Figure 2).
Cancers of the prostate, lung & bronchus, and colon & rectum were the most frequently 
diagnosed malignancies among males in both Guam and Hawaii (Table 1). Cancers of the 
lung & bronchus, liver & intrahepatic bile duct, and nasopharynx were of significantly 
higher incidence among Guam compared to Hawaii males. Rates of liver & intrahepatic bile 
duct cancer among Guam males was nearly double and nasopharyngeal cancers more than 
four times higher than that of men in Hawaii.
Melanoma of the skin, the 4th most common malignancy among Hawaii males, was rare in 
Guam. Other cancers with significantly lower incidence among Guam compared to Hawaii 
males included bladder, kidney & renal pelvis, pancreas, and non-Hodgkin lymphoma. The 
incidence of pancreatic cancer and non-Hodgkin lymphoma was more than two-fold lower 
among Guam compared to Hawaii males.
In 2009-2013, cancers of the breast, lung & bronchus, colon & rectum, uterus/endometrium, 
and thyroid were the most frequently diagnosed malignancies among females in both Guam 
and Hawaii (Table 2). Cancers with significantly lower incidence among Guam compared to 
Hawaii females included breast, colon & rectum, uterus/endometrium, non-Hodgkin 
lymphoma, skin melanoma, pancreas, leukemia, ovary, and kidney & renal pelvis. Cervical 
cancer was the only major cancer with higher incidence in Guam females; rates were was 
nearly double that of Hawaii.
Ethnic differences in incidence were observed for some of the major cancers in Guam. The 
incidence of liver & intrahepatic bile duct cancer among Chamorro men (41.9, 95% CI 31.3 
– 54.9) was significantly higher than that of Filipinos (10.3, 95% CI 5.6 – 17.6) and Whites 
(10.5, 95% CI 2.8 – 28.2) in Guam as well as Native Hawaiians (17.5, 95% CI 14.5 – 21.0) 
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who had the highest incidence in Hawaii. Similarly, Chamorro men had an elevated 
incidence of lung & bronchus cancer (73.6, 95% CI 59.4 – 90.2) compared to Filipinos 
(31.9, 95% CI 23.2 – 43.1) and Whites (42.5, 95% CI 22.6 – 72.4) in Guam. Their rates also 
exceeded that of Native Hawaiians (52.7, 95% CI 47.1 – 58.7) who had the highest statewide 
rates. Non-significant higher rates of nasopharyngeal cancer were observed in Chamorro 
males (8.1, 95% CI 4.3 – 14.3) compared to Filipino (4.2, 95% CI 1.5 – 9.5) and White (2.5, 
95% CI 0.1 – 15.8). Among Guam females, cervical cancer incidence was highest in 
Chamorros (14.8, 95% CI 9.5 – 22.1) compared to Filipinos (4.2, 95% CI 1.3 – 10.2) and 
Whites (9.3, 95% CI 1.0 – 35.6).
Cancer Mortality
In 2009-2013, there were 760 (152 per year) cancer deaths in Guam and 11,144 (2,229 per 
year) in Hawaii. Overall cancer mortality was significantly higher among Guam males 
(130.6, 95% CI 118.7 – 143.5) compared to Hawaii males (111.5, 95% CI 108.6 – 114.4). 
Among females, mortality was comparable in Guam and Hawaii (80.2, 95% CI 71.3 – 89.8) 
and (78.2, 95% CI 75.9 – 80.6), respectively.
Overall cancer mortality varied by ethnicity in both Guam and Hawaii. In 2009-2013, among 
males in Guam, mortality was significantly higher in Chamorros (198.3, 95% CI 170.6 – 
229.0). and Whites (160.6, 95% CI 114.6 – 217.6) compared to Filipinos (74.1, 95% CI 60.2 
– 90.3). Similarly, among females, mortality was significantly higher in Chamorros (105.2, 
95% CI 89.7 – 122.6) and Whites (96.5, 95% CI 51.7 – 160.9) compared to Filipinos (35.5, 
95% CI 26.2 – 47.3). In Hawaii, the highest cancer mortality was observed among Native 
Hawaiians. Cancer mortality in Native Hawaiian males (156.6, 95% CI 146.9 – 166.7) was 
significantly lower than Chamorro men. In contrast, mortality in Native Hawaiian females 
(130.3, 95% CI 122.2 – 138.8) was significantly higher than Chamorro women.
Lung & bronchus cancer was the top cause of cancer death among males in both populations 
although rates were significantly higher in Guam compared to Hawaii (Table 3). For other 
major causes of cancer death in men, rates were also significantly higher in Guam compared 
to Hawaii for cancers of the prostate and liver & intrahepatic bile duct.. Nasopharyngeal 
(NPC) cancer deaths also significantly higher among men in Guam compared to Hawaii. 
Pancreatic cancer mortality was significantly lower among Guam compared to Hawaii 
males.
Lung & bronchus cancer was also the leading cause of cancer death among females in Guam 
and Hawaii although rates were highest in Guam (Table 4). Mortality was comparable in 
Guam and Hawaii females for most other major cancers. Similar to males, pancreatic cancer 
mortality was higher among females in Guam than in Hawaii.
Mortality rates varied across Guam's ethnic populations. Lung & bronchus cancer mortality 
among Chamorro men (62.1, 95% CI 47.7 – 79.1) was more than double that of Filipinos 
(24.2, 95% CI 16.6 – 34.2) and Whites (29.2, 95% CI 12.5 – 56.9). Lung & bronchus cancer 
mortality among Chamorro males also exceeded that of Native Hawaiians (40.8, 95% CI 
35.9 – 46.1) who had the highest rates in Hawaii. Liver & intrahepatic bile duct cancer 
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mortality was more than two times higher in Chamorro males (27.0, 95% CI 19.2 – 37.1) 
compared to Filipinos (5.9, 95% CI 2.5 – 11.9) and Whites (10.8, 95% CI 2.7 – 29.1).
Filipinos and Whites in Guam and Hawaii
Comparison of cancer incidence and mortality in Filipinos and Whites residing in Guam 
with their ethnic counterparts in Hawaii demonstrated striking differences. Overall cancer 
incidence was significantly lower among Filipinos residing in Guam than Filipinos in 
Hawaii (males: 150.2, 95% CI 130.3 – 172.3 and 295.6, 95% CI 283.5 – 308.1, respectively; 
females: 147.5, 95% CI 127.0 – 170.5 and 280.2, 95% CI 269.0 – 291.9, respectively). 
Significantly lower incidence was observed among Filipinos in Guam compared to those in 
Hawaii for a number of major cancers: prostate (39.1, 95% CI 29.3 - 51.4 and 76.8, 95% CI 
70.9 – 83.2, respectively); breast (62.0, 95% CI 49.2 – 77.4 and 86.9, 95% CI 80.7 – 93.5, 
respectively); colon & rectum (males: 27.0, 95% CI 19.1 – 37.4 and 43.8, 95% CI 39.2 – 
48.8, respectively; females: 10.1, 95% CI 5.3 – 17.7 and 30.1, 95% CI 26.6 – 34.0, 
respectively); lung & bronchus (males: 31.9, 95% CI 23.2 – 43.1 and 47.4, 95% CI 42.7 – 
52.4, respectively; females: 12.9, 95% CI 7.6 – 20.9 and 24.7, 95% CI 21.7 – 28.1, 
respectively) ; uterus/endometrium (13.2, 95% CI 7.7 – 21.4 and 20.2, 95% CI 17.2 – 23.6, 
respectively); and thyroid (females: 20.2, 95% CI 12.8 – 30.4 and 35.1, 95% CI 30.8 – 39.9, 
respectively). Rates of thyroid cancer among Filipinas in both Guam and Hawaii were the 
highest in their respective populations. Overall cancer mortality was also substantially lower 
among Filipinos in Guam compared to Filipinos in Hawaii (males: 74.1, 95% CI 60.2 – 90.3 
and 99.2, 95% CI 92.4 – 106.4, respectively; females: 35.5, 95% CI 26.2 – 47.3 and 69.8, 
95% CI 64.6 – 75.4, respectively).
Whites in Guam had significantly lower overall cancer incidence than Whites in Hawaii 
(males: 314.7, 95% CI 253.1 – 386.2 and 414.7, 95% CI 403.6 – 426.1, respectively; 
females: 212.6, 95% CI 142.1 – 302.6 and 378.1, 95% CI 366.2 – 390.3, respectively). 
There were no cases of melanoma among Whites in Guam. In contrast, melanoma was one 
of the most common cancers among Whites in Hawaii who comprised 84% (1,341/1,601) of 
cases. Overall mortality was higher among Whites in Guam than in Hawaii (males: 160.6, 
95% CI 114.6 – 217.6 and 117.1, 95% CI 111.6 – 122.9, respectively). Mortality rates were 
similar for White females in Guam and Hawaii (females: 96.5, 95% CI 51.7 – 160.9 and 
86.1, 95% CI 81.0 – 91.5, respectively).
Age at Cancer Diagnosis
Guam cancer patients were diagnosed at significantly younger ages than Hawaii patients 
(Figure 3). Overall, the mean age at diagnosis in Guam and Hawaii was 62.8 years and 65.8 
years, respectively, for males (p <0.0001) and 57.8 years and 63.1 years, respectively, for 
females (p<0.0001). Younger mean age at diagnosis was also observed in Guam compared 
to Hawaii for cancers of the bladder in men (66.4 vs. 71.8; p=0.008), pancreas in men (57.2 
vs. 69.1, p<0.0001), breast in women (57.9 vs. 61.5; p<0.0001), colon & rectum in women 
(60.6 vs. 66.7; p=0.0001), non-Hodgkin lymphoma in females (58.0 vs. 66.4; p=0.009), 
leukemia in both sexes (48.6 vs. 61.3; p=0.04 in males; 39.0 vs. 58.5; p=0.003 in females), 
liver & intrahepatic bile duct in both sexes (57.9 vs. 63.8; p<0.0001 in males; 60.4 vs. 70.7; 
p=0.0009 in females), lung & bronchus in both sexes (66.0 vs. 70.3; p<0.0001 in males; 64.3 
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vs. 70.4; p<0.0001 in females), and stomach in both sexes (62.9 vs. 69.6, p=0.03 in males; 
62.1 vs. 70.9, p=0.0098 in females). These age differences were also significant based on 
non-parametric tests (data not shown).
Breast cancer in Guam and Hawaii
In addition to the significantly lower incidence and younger age of diagnosis of female 
breast cancer cases in Guam compared to Hawaii, histologic differences were observed. 
Infiltrating duct carcinoma comprised 71% (169/239) of Guam breast cancer cases 
compared to 81% (4,488/5,536) of Hawaii cases (p<0.0001). Less common histologies were 
more prevalent in Guam breast cancers. Inflammatory carcinoma comprised 2% (4/239) of 
Guam breast cancer cases and only 0.1% (6/5,536) of Hawaii cases (p<0.0001). Infiltrating 
ductular carcinoma made up 2% (4/239) and 0.2% (10/5,536) of Guam and Hawaii cases, 
respectively (p<0.0001). Infiltrating duct mixed with other types comprised 5% (11/239) of 
Guam cases and 2% (104/5,536) of Hawaii cases (p=0.0032).
Molecular subtypes could not be compared due to the lack of complete information on ER, 
PR, and HER2 for Guam cases. There was no difference in the stage at diagnosis with the 
localized breast tumors representing 62% (15/185) and 69% (3,654/5,335) (p=0.19) of cases 
in Guam and Hawaii, respectively. Information on screening history within the two years 
prior to diagnosis was available for Guam. Among breast cancer cases, 78% (184/237) had a 
mammogram within two years prior to diagnosis. There was no difference in stage between 
screened and unscreened cases (data not shown). Screening history was not available for 
Hawaii cases.
Discussion
Contrasting cancer patterns within Guam and between Guam and Hawaii underscore the 
potential influence of genes, lifestyle, and environment on cancer development and 
progression. Guam males and, in particular, Chamorros, are disproportionately affected by 
poor outcomes for a number of major cancers. Malignancies of the lung & bronchus account 
for the largest cancer burden in both Guam and Hawaii and is one of the most commonly 
diagnosed cancers and the leading cause of cancer deaths. The incidence of lung & bronchus 
cancer in Guam males was far higher than that of Hawaii males and slightly exceeded 
overall U.S. rates.[20] This is consistent with the historically high prevalence of cigarette 
smoking in Guam which was estimated at 31% in 2001, the highest of all U.S. states and 
territories.[14] In Guam, lung & bronchus cancer incidence was highest among Chamorro 
males. In Guam lung & bronchus patients were diagnosed an average of 4-5 years younger 
than Hawaii patients. This may reflect an earlier age of smoking initiation in Guam, which is 
consistent with the observed higher mortality rates as duration of smoking is a strong 
predictor of lung & bronchus cancer death.[21] Early age of smoking initiation may also 
account for the younger age of cancer onset in Guam compared to Hawaii for malignancies 
of the bladder, pancreas, liver & intrahepatic bile duct, and stomach, which are all linked to 
cigarette smoking.[22]
The high incidence of liver & intrahepatic bile duct cancer among men in Guam, which was 
nearly twice that of Hawaii males, is particularly striking given that Hawaii has one of the 
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highest rates in the U.S.[20] Liver cancer is one of the fastest rising cancers and causes of 
cancer death in the U.S.[20] The extremely high rates in Chamorro men underscores the 
potential contribution of multiple independent and, possibly, synergistic risk factors. It is 
likely that liver cancers caused by hepatitis B (HBV) have declined in Guam since 1988 
when HBV infant vaccination became universally available.[23] Conversely, liver cancers 
related to hepatitis C (HCV) may be increasing in Guam as it is in Hawaii and the U.S. 
resulting from rising rates of chronic HCV in individuals acutely infected decades earlier 
likely through parenteral exposure, including intravenous drug use, or transfusion-related 
exposure to contaminated blood products, as well as sexual transmission.[20] Haddock el al 
reported that 63% of liver cancer cases were attributed to HCV and Chamorros had the 
highest incidence of HCV infection.[23] In addition to HCV, smoking, alcohol consumption, 
and other factors may also be driving the high rates of liver cancer in Guam. Chewing of 
betel nut, which comes from the Areca catechu palm tree, is widely practiced throughout 
Micronesia including among Chamorros in Guam. [15, 22] There is some evidence that betel 
nut chewing may act synergistically with HBV and HCV to increase the risk of liver cancer. 
[22, 24-26] Chamorros have a high prevalence of obesity [27], which has been increasingly 
recognized as a risk factor for liver cancer contributing to the rising rates in the U.S. [28] 
Notably, betel nut chewing is linked to obesity. [29, 30]
Nasopharyngeal cancer (hereafter NPC) was a top cancer in Guam particularly among 
Chamorro men, and a major cause of cancer death in Guam. In contrast, NPC was rare in 
Hawaii. The incidence of NPC varies widely across the globe with the highest incidence in 
eastern and southeastern Asia. [31] The high mortality of NPC in Guam is consistent with its 
typical presentation as an advanced, metastatic tumor.[32] NPC is etiologically linked to 
Epstein-Barr virus (EBV) [33], a common, orally-transmitted infection with most 
individuals infected by early adulthood. [33] Primary EBV infection in early childhood 
typically occurs in developing areas where crowded living conditions as well as practices 
such as pre-chewing of foods for young children contribute to transmission. [33] In more 
developed areas, EBV infection is often delayed until adolescence when transmission 
typically occurs through kissing and other salivary contact. [33] Following primary 
infection, EBV is maintained as a latent infection and carcinogenesis may be induced with 
its reactivation. In addition to EBV, other factors may be influencing the elevated risk of 
NPC in Guam including the high prevalence of smoking, a risk factor for NPC. [22] The 
chewing of betel nut with added tobacco is also a risk factor for NPC. [22] In Guam, betel 
nut is typically chewed alone or combined with betel leaf, tobacco, and/or slaked lime. [15]
Cancers of the oral cavity & pharynx (excluding nasopharynx) were among the top 
malignancies among men in both Guam and Hawaii. Smoking and betel nut chewing are 
presumably important factors contributing to Guam's high incidence of oral cavity & 
pharyngeal cancers other than NPC. Betel nut chewing with or without added tobacco is an 
established risk factor for cancers of the oral cavity and, with the addition of tobacco, it is 
also causally linked to cancers from other subsites of the pharynx. [22] In Hawaii, where 
betel nut use is not widespread, human papillomavirus (HPV), primarily genotypes 16 and 
18, may play a more important role. HPV has been increasingly recognized as a causal agent 
in oropharyngeal and, to a lesser extent, oral cavity tumors, in the U.S. [34, 35] In a study of 
oropharyngeal cancer cases over a twenty-year period in Hawaii, Iowa, and Los Angeles 
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County, HPV-positive cases were shown to increase over time while HPV-negative cases, 
presumed to be smoking-related, decreased. [36]
HPV is also the primary cause of cervical cancer,[37] one of the top cancers among women 
in Guam with rates double that of Hawaii women. The burden of cervical cancer is 
particularly high among Chamorro women. Steady declines in cervical cancer incidence and 
mortality in the U.S. over the past several decades have been attributed to widespread Pap 
screening. [38] Today, the majority of cervical cancers in the U.S. occur in women who have 
not been appropriately screened and present at advanced stages.[38]
The incidence of breast cancer in Guam, which was substantially lower than Hawaii, is 
lower than all 50 U.S. states. [39] The lower incidence combined with the higher mortality 
in Guam compared to Hawaii suggests lower rates of breast cancer screening and/or issues 
related to access to care in Guam resulting in more advanced stage breast cancers. 
Nonetheless, there was no difference in the stage distribution of breast cancers. Moreover, 
registry records indicate that most Guam breast cancer patients had received breast screening 
in the two years prior to diagnosis. The younger age of diagnosis in Guam breast cancer 
patients compared to Hawaii may account for the higher mortality rates. Premenopausal 
breast cancers tend to be more aggressive, including a larger proportion of triple-negative 
tumors. [40] Guam breast cancers included a greater proportion of rare histologic subtypes 
including inflammatory breast cancer, an aggressive tumor more common in younger 
women and characterized by rapid onset, progression, and poor survival. [41, 42]
Cancer incidence among the same ethnic groups residing in Guam and Hawaii illustrate the 
potential influence of genes and environment on cancer risk. Hawaii Filipinos experienced 
higher incidence of a number of major cancers compared to Filipinos in Guam. Hawaii 
Filipinos may have adopted Western diets and lifestyles to a greater extent than Filipinos in 
Guam contributing to a higher prevalence of obesity-related cancers including colon & 
rectum, postmenopausal breast, ovary, endometrium, and thyroid. [43] Although thyroid 
cancer incidence was higher among Filipinas in Hawaii than in Guam, the rates among 
Filipinas in Guam was the highest in the population. The excess risk of thyroid cancer 
among Filipinas has long been recognized in Hawaii [44] and has also been observed among 
Filipinas residing on the U.S. mainland [45, 46] suggesting genetic susceptibility as well as 
lifestyle and environmental factors.
Melanoma of the skin was top cancer in Hawaii, with over 80% of cases diagnosed in 
Whites. In contrast, melanoma was a rare malignancy in Guam's population, including 
Whites. The elevated risk of melanoma among Whites in Hawaii has long been recognized 
and multiple risk factors include fair complexion and freckling, excess sun exposure and 
sunburn, and length of residence in Hawaii.[11] Whether the rarity of melanoma is Guam 
can be attributed to reduced sun exposure or other differences in lifestyle factors is 
unknown.
Different lifestyle practices and living conditions in Guam compared to Hawaii may enhance 
exposure to infectious agents that increase the risk of a number of cancers. The prevalence 
of cigarette smoking, which has fallen in the U.S. general population, may be slower to 
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decrease in Guam leading to the continued prominence of smoking-related cancers. Betel 
nut chewing also appears to be an important factor influencing cancer risk in Guam.
The present evaluation provides a comparison of cancer incidence and mortality in two U.S. 
multiethnic populations. The comparison was strengthened by the availability of data from 
population-based central cancer registries. Some limitations in Guam data completeness 
were noted. Comparisons of stage were limited by the large proportion of unstaged cases in 
Guam. The reason for the lack of staging is unclear. There is some evidence that unstaged 
diagnoses in the U.S. are more prevalent with lethal cancers and in certain patient groups 
including the elderly. [47] However, we were unable to evaluate this within the context of 
the present report. The influence of access to treatment on cancer outcome could not be 
evaluated as information on medical insurance coverage was not available from registry data 
in Guam and Hawaii. Ethnic comparisons were limited by the relatively small case and 
population numbers in Guam. Chuukese and other less populous groups could not be 
separately evaluated. As this analysis was limited to a 5-year time period, inferences could 
not be made regarding trends in cancer rates.
Guam and Hawaii uniquely represent among the most ethnically diverse U.S. populations. 
Cancer disparities in Guam and their contrasts with that of Hawaii provide insight into the 
potential interaction of genetic, lifestyle, and environmental factors influencing the 
development of cancer. These disparities also underscore the importance of strategies for 
cancer prevention and early detection targeted to these multiethnic communities.
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Figure 1. Overall Cancer Incidence, 1 Guam, 2009 – 2013
1Average annual rates age-adjusted to the World (WHO 2000-2025) Standard Million 
Population
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Figure 2. Overall Cancer Incidence, 1 Hawaii, 2009 – 2013
1Average annual rates age-adjusted to the World (WHO 2000-2025) Standard Million 
Population
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Figure 3. Younger Age of Cancer Diagnosis (p<0.05) in Guam vs. Hawaii
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